{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-037389","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2024-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.239609+00:00","generated_at":"2026-06-04T09:59:10.409296+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NRx Pharmaceuticals shareholders approve reverse stock split proposal with 94.4% support","bullets":["94.4% (53,597,974) of votes cast at March 21, 2024 special meeting favor reverse split.","Board authorized to effect split at ratio of 1-for-2 to 1-for-15 within one year.","61.4% (56,781,354) of eligible shares voted despite internet campaign to suppress vote.","Company expects to share annual report on March 28 and update investors on progress."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-037389","json":"https://secwatch.observer/filing/0001104659-24-037389.json","markdown":"https://secwatch.observer/filing/0001104659-24-037389.md","text":"https://secwatch.observer/filing/0001104659-24-037389.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000110465924037389/0001104659-24-037389-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000110465924037389/tm2333863d6_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:59:10.409296+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c56df88ef7ae249377f24cdcfda490ae0f553297","claim":"NRX Pharmaceuticals, Inc. shareholders approved Reverse stock split of all outstanding shares at a ratio in the range of 1-for-2 to 1-for-15 at the 2024-03-21 meeting.","evidence_excerpt":"Proposal 1. The Company’s stockholders approved an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board of Directors of the Company (the “Board”) but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company’s stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of the Company’s common stock, $0.001 par value per share, at a ratio in the range of 1-for-2 to 1-for-15, with such ratio to be determined by the Board in its discretion and included in a public announcement.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1719406/000110465924037389/0001104659-24-037389-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-21"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}